CD8A and neoplasm: Silencing of LINC00460 reduces the tumor growth of PC through anti-PD-1 therapy and enhances the sensitivity of PANC-1 cells to cytotoxicity of CD8+T cells via regulation of the miR-503-5p/ANLN axis